A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem.

导出原文传递

翻译打印收藏纠错

第一作者： Yujuan,Zhang

第一单位： Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.;Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China.

作者： Yujuan,Zhang ^[1] ; Jiamin,Fu ^[1] ; Yanmei,Shi ^[1] ; Shanshan,Peng ^[2] ; Ying,Cai ^[1] ; Xuelin,Zhan ^[1] ; Na,Song ^[1] ; Yanling,Liu ^[1] ; Zhigang,Wang ^[1] ; Yanrong,Yu ^[1] ; Yifan,Wang ^[1] ; Qiaofa,Shi ^[3] ; Yingyuan,Fu ^[3] ; Keng,Yuan ^[1] ; Nanjin,Zhou ^[1] ; Rakesh,Joshi ^[4] ; Thomas E,Ichim ^[5] ; Weiping,Min ^[2]

作者单位： Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.;Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China. ^[1] Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China.;Jiangxi Provincial Key Laboratory of Immunotherapy, Nanchang, China.;Department of Surgery, Pathology and Oncology, University of Western Ontario, London, ON, Canada. ^[2] Institute of immunotherapy and College of Basic Medicine of Nanchang University, and Jiangxi Academy of Medical Sciences, Nanchang, China. ^[3] Department of Surgery, Pathology and Oncology, University of Western Ontario, London, ON, Canada. ^[4] Batu Biologics Inc., San Diego, CA. ^[5]

关键词 Flt3-L dendritic cells immunostimulatory nanosystem lung cancer siIDO